Abstract Details
9/07/2025 | 4:00 PM - 5:00 PM | Instructional Session | University Hall
Congenital CMV 101- Updates on What you Need to Know and Remember!
Abstract Summary
This instructional session is a great start to the meeting to help attendees be prepared to understand CMV basics and recent updates relevant to congenital CMV. Basics and updates on biology, epidemiology, transmission, diagnosis, treatment, management, and prevention of CMV infection in pregnancy and in newborns and infants will be presented in a fast paced, high level, overview, didactic session. Updates on CMV advocacy efforts also will be presented. Elephants will help attendees remember important facts!
Learning Objectives
- Understand the basic biology, epidemiology and transmission of CMV
- Understand recent updates in diagnosis and management of CMV infection in pregnant persons and their infants
- Apply knowledge about prevention of CMV in the family and community, and how advocacy efforts can provide meaningful context for awareness
Presentation
This presentation has not yet been uploaded.
Handouts
No handouts have been uploaded.
Presenters
Gail Demmler-Harrison | POC, Primary Presenter
gdemmler@bcm.edu;
Dr. Gail Demmler-Harrison is Professor of Pediatrics at Baylor College of Medicine, Attending Physician Infectious Diseases Service and CMV Clinic Lead at Texas Children’s Hospital, Houston, Texas. Her research, clinical experience, and expertise has focused for over 40 years on the epidemiology, diagnosis, treatment, prevention and long term outcomes of cytomegalovirus (CMV) infections in pregnant persons and their newborns. Her research has defined congenital CMV as a lifelong condition and helped change the standard of care for these children, including monitoring for sensorineural hearing loss progression and later onset hearing loss in children affected by congenital CMV. She has been instrumental in advocating for the passage of CMV education and CMV newborn screening laws, and CMV awareness.
She is the author or co-author of hundreds of scientific and educational publications, book chapters, on line videos, and has presented hundreds of invited lectures and original science presentations.
ASHA DISCLOSURE
Financial - Receives Royalty options or other ownership interest for Other activities from Elsevier. Receives Speaker for Teaching and speaking from Medscape WEBMD. Receives Consulting fee,Grants for Consulting,Independent contractor from Merck. Receives Consulting fee,Grants for Consulting,Independent contractor from Microgen Labs. Receives Consulting fee,Grants for Consulting,Independent contractor from Moderna. Receives Consulting fee,Honoraria excluding diversified mutual funds,Other financial benefit for Teaching and speaking,Consulting from WEBMD Medscape. Receives Royalty options or other ownership interest for Other activities from Wolters Kluwer UpToDate.
Nonfinancial - No relevant nonfinancial relationship exists.
AAA DISCLOSURE
Financial - Receives support from Moderna, Merck, Microgen Labs, Elsevier, Wolters/Kluwer, WEBMD Medscape for Research and spoken or written topics related to congenital infections, including congenital CMV, and neonatal infections, including neonatal HSV, and also pediatric infectious diseases in general; all activities are research/scholarly/educational and/or CME certified..